About Us

Afton Scientific’s Established Excellence and Innovation

Who We Are

Afton Scientific is a recognised leader in sterile injectable manufacturing, defined by a strong commitment to quality, reliability and innovation. With a history spanning more than 20 years, we work in partnership with global clients to advance pharmaceutical science with precision and integrity. Our mission is to deliver high-quality solutions while fostering a culture built on collaboration, accountability and continuous improvement.

Our History
& Legacy

2004

Opened our first cGMP aseptic filling facility.

2005

Commenced production of pre-sterilised components.

2006

Received initial ANDA approvals from the FDA.

2007

Established a second facility incorporating component manufacturing capabilities.

2021

Secured FDA approval for drug production on a second manufacturing line.

2024

Received initial external investment to support expansion.

2025

Expanded analytical and microbiology laboratory facilities and capabilities.

2025

Commenced construction of a new manufacturing facility.

2026

Installation and validation of an isolator filling line.

Our Expertise and Capabilities

At Afton Scientific, our capabilities cover aseptic processing, sterile components and advanced fill/finish operations. We specialise in biologics, small molecules and emerging modalities, delivering tailored solutions that address complex manufacturing requirements while upholding rigorous standards.

  • Explore Our Manufacturing Capabilities

  • Learn About Our Laboratory Services

Our Commitment to Quality

Quality underpins every aspect of our operations at Afton Scientific. Our robust Quality Management System (QMS) reflects our commitment to continuous improvement, rigorous regulatory compliance and the adoption of advanced technologies. With a strong regulatory track record and a history of successful inspections, we provide our clients with confidence, delivering consistent quality in every batch.

Our Growth and Future Roadmap

Afton Scientific continues to invest in future growth through strategic expansion and service development. In 2026, we will introduce a new pre-filled syringe and cartridge filling line, followed by the opening of a new facility in 2027 to increase capacity and create more than 200 new roles. Our roadmap also includes further capacity expansion, the introduction of new technologies and enhanced laboratory capabilities, ensuring we are well positioned to meet the evolving needs of our clients.

Partner with Afton Scientific

Our team is ready to support your pharmaceutical manufacturing objectives.